radiotheranostics

Showing 1 posts of 1 posts found.

money_pills_2

VIVES Partners contributes to €84m funding for radiopharma company, Nuclidium

July 14, 2025
Medical Communications, Research and Development Nuclidium, Oncology, VIVES Funds, VIVES Partners, radiopharmaceuticals, radiotheranostics

VIVES Partners, the managing company of VIVES Funds, has announced that it will contribute to an €84m Series B financing …

The Gateway to Local Adoption Series

Latest content